A disulfidptosis-related lncRNA signature for analyzing tumor microenvironment and clinical prognosis in hepatocellular carcinoma
In general, this multifaceted approach provides a comprehensive overview of DRLs profiles in HCC, culminating in the establishment of a novel risk signature that holds promise for predicting prognosis and therapy outcomes of HCC patients.
Authors
- Ziyun Zhuang (ORCID: https://orcid.org/0000-0001-7969-6888)
- Jigan Cheng
- Duguang Li
- Fan Yuan (ORCID: https://orcid.org/0000-0002-0687-6607)
- Haishui Zheng
- Xiaolong Liu (ORCID: https://orcid.org/0000-0003-1236-1332)
- Jing Yang (ORCID: https://orcid.org/0000-0001-6646-3401)
- Xiaoxiao Fan
Institutions
- Sir Run Run Shaw Hospital (CN)
- Shantou University (CN)
- Shantou University Medical College (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-10-07
- DOI
- https://doi.org/10.3389/fimmu.2024.1412277
- Citations
- 5
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 1.43